Stock GSD DEVONIAN HEALTH GROUP INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Devonian Health Group Inc.

Equities

GSD

CA2518341078

Pharmaceuticals

Market Closed - Toronto S.E.
Other stock markets
 03:01:37 2024-04-23 pm EDT 		5-day change 1st Jan Change
0.22 CAD 0.00% Intraday chart for Devonian Health Group Inc. 0.00% +51.72%
Mar. 28 Devonian Health Group Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024 CI
Mar. 14 Devonian Health Group Closes Non-Brokered Private Placement; Down Nearly 7% MT

Valuation

Fiscal Period: July 2018 2019 2020 2021 2022 2023
Capitalization 1 31.2 19.18 13.2 44.91 59.01 39.73
Enterprise Value (EV) 1 34.49 23.38 16.97 49.84 55.49 38.34
P/E ratio -8.33 x -5.66 x -2.65 x -12.6 x -15.5 x -8.09 x
Yield - - - - - -
Capitalization / Revenue 9.75 x 3.23 x 6.16 x 30.5 x 25.6 x 16.9 x
EV / Revenue 10.8 x 3.94 x 7.92 x 33.8 x 24.1 x 16.3 x
EV / EBITDA -15.7 x -10.7 x -5.54 x -38.5 x -26.8 x -9.77 x
EV / FCF -32 x -91.3 x -21.9 x -55.9 x -25.9 x -15.2 x
FCF Yield -3.13% -1.09% -4.57% -1.79% -3.86% -6.59%
Price to Book 2.25 x 1.68 x 1.41 x 5.96 x 3.63 x 2.79 x
Nbr of stocks (in thousands) 73,417 76,737 82,523 93,562 131,139 144,458
Reference price 2 0.4250 0.2500 0.1600 0.4800 0.4500 0.2750
Announcement Date 11/28/18 11/28/19 11/30/20 11/26/21 11/28/22 11/28/23
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: July 2018 2019 2020 2021 2022 2023
Net sales 1 3.2 5.938 2.143 1.475 2.305 2.345
EBITDA 1 -2.197 -2.177 -3.062 -1.296 -2.07 -3.925
EBIT 1 -2.837 -3.19 -4.085 -2.306 -2.913 -4.324
Operating Margin -88.67% -53.73% -190.61% -156.37% -126.35% -184.37%
Earnings before Tax (EBT) 1 -3.284 -3.223 -4.375 -3.346 -3.448 -4.6
Net income 1 -3.187 -2.979 -4.375 -3.346 -3.448 -4.6
Net margin -99.6% -50.18% -204.13% -226.92% -149.59% -196.11%
EPS 2 -0.0510 -0.0442 -0.0604 -0.0380 -0.0290 -0.0340
Free Cash Flow 1 -1.078 -0.256 -0.7754 -0.8922 -2.144 -2.527
FCF margin -33.7% -4.31% -36.18% -60.5% -92.99% -107.76%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 11/28/18 11/28/19 11/30/20 11/26/21 11/28/22 11/28/23
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: July 2018 2019 2020 2021 2022 2023
Net Debt 1 3.29 4.19 3.77 4.93 - -
Net Cash position 1 - - - - 3.53 1.39
Leverage (Debt/EBITDA) -1.497 x -1.926 x -1.231 x -3.805 x - -
Free Cash Flow 1 -1.08 -0.26 -0.78 -0.89 -2.14 -2.53
ROE (net income / shareholders' equity) -30.5% -26.1% -43.2% -39.6% -29% -30.1%
ROA (Net income/ Total Assets) -11.5% -11% -15.1% -9.21% -10.1% -13.3%
Assets 1 27.6 27.12 28.97 36.34 34.28 34.69
Book Value Per Share 2 0.1900 0.1500 0.1100 0.0800 0.1200 0.1000
Cash Flow per Share 2 0.0100 0 0.0100 0 0.0200 0.0400
Capex - - - - 0.07 -
Capex / Sales - - - - 3.2% -
Announcement Date 11/28/18 11/28/19 11/30/20 11/26/21 11/28/22 11/28/23
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
DEVONIAN HEALTH GROUP INC. Stock Devonian Health Group Inc.
+51.72% 23.82M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. GSD Stock
  4. Financials Devonian Health Group Inc.